How to buy Aspira Womens Health stock (AWH)

Aspira Womens Health is a diagnostics & research business based in the US. Aspira Womens Health shares (AWH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.94 – a decrease of 12.15% over the previous week. Aspira Womens Health employs 64 staff and has a trailing 12-month revenue of around $8.9 million.

Our top picks for where to buy Aspira Womens Health stock

Buy Aspira Womens Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Aspira Womens Health stock price (NASDAQ: AWH)

Use our graph to track the performance of AWH stocks over time.

Aspira Womens Health shares at a glance

• Key figures

Information last updated 2024-10-24.

Latest market close	$0.94
52-week range	$0.74 - $5.65
50-day moving average more info button	$0.90
200-day moving average more info button	$2.44
Wall St. target price	$4.25
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.41

Is it a good time to buy Aspira Womens Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aspira Womens Health price performance over time

Historical closes compared with the close of $0.965 from 2024-10-25

1 week (2024-10-22)	-9.81%
1 month (2024-09-27)	16.97%
3 months (2024-07-29)	-34.80%
6 months (2024-04-29)	-71.02%

1 year (2023-10-27)	-79.02%
2 years (2022-10-28)	147.44%
3 years (2021-10-29)	3.35
5 years (2019-10-29)	62.21%

Aspira Womens Health financials

Revenue TTM	$8.9 million
Gross profit TTM	$4.3 million
Return on assets TTM	-185.71%
Return on equity TTM	-723.45%
Profit margin	-178.8%
Book value	$-0.29
Market Capitalization more info button	$15.7 million

TTM: trailing 12 months

Aspira Womens Health share dividends

We're not expecting Aspira Womens Health to pay a dividend over the next 12 months.

Have Aspira Womens Health's shares ever split?

Aspira Womens Health's shares were split on a 1:15 basis on 11 May 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aspira Womens Health shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Aspira Womens Health shares which in turn could have impacted Aspira Womens Health's share price.

Aspira Womens Health share price volatility

Over the last 12 months, Aspira Womens Health's shares have ranged in value from as little as $0.738 up to $5.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aspira Womens Health's is 1.467. This would suggest that Aspira Womens Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Aspira Womens Health overview

Aspira Women's Health Inc. , together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC.

Frequently asked questions

null
What percentage of Aspira Womens Health is owned by insiders or institutions?
Currently 30.943% of Aspira Womens Health shares are held by insiders and 8.683% by institutions. How many people work for Aspira Womens Health?
Latest data suggests 64 work at Aspira Womens Health. When does the fiscal year end for Aspira Womens Health?
Aspira Womens Health's fiscal year ends in December. Where is Aspira Womens Health based?
Aspira Womens Health's address is: Building III, Austin, TX, United States, 78738 What is Aspira Womens Health's ISIN number?
Aspira Womens Health's international securities identification number is: US04537Y1091